Bivalirudin Versus Heparin Plus a Glycoprotein IIlb/IIIa Inhibitor in Patients With Non-ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment.

Authors :: Ndrepepa, Gjin
Neumann, Franz-Josef
Deliargyris, Efthymios N.
Mehran, Roxana
Mehilli, Julinda
Ferenc, Miroslaw
Schulz, Stefanie
Sc&oumlhmig, Albert
Kastrati, Adnan
Stone, Gregg W.
Source :: Circulation: Cardiovascular Interventions; Oct2012, Vol. 5 Issue 5, p705-712, 8p
Publication Year :: 2012
Abstract: The article discusses a research study on comparing the safety and efficacy of bivalirudin and heparin with additional glycoprotein IIb/IIIa inhibitor (GPI) in patients with elevated non-ST-segment myocardial infarction (MI) after pretreatment with clopidogrel. Study subjects include 3798 patients in the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) setting. Results showed superiority of bivalirudin to heparin plus GPI in bleeding reduction.

Subjects :: MYOCARDIAL infarction treatment
CLOPIDOGREL
HEPARIN
ACUTE coronary syndrome
CORONARY disease

Full Text Access

Tools